Identification of activating FcγRs as mediators of Ab-induced inhibition of axon regeneration is relevant to the clinical observations showing that certain polymorphisms in activating FcγR genes correlated with risk of developing GBS, severity of disease, and prognosis [42], [43]. Here, FCGR2A is linked to Guillain-Barre syndrome.